Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product segment
1.2.2. Application segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.3.2. Data validation & publishing
1.4. Research Assumptions
1.5. Information Procurement
1.5.1. Primary research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Global Market: CAGR Calculation
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends & Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Expansion in scope of applications for cell culture technology
3.3.1.2. Rising demand for biopharmaceuticals, artificial organs, & vaccine production
3.3.1.3. Growth in demand for serum-free, specialty, and customized media
3.3.2. Market Restraint Analysis
3.3.2.1. Stringent process control in cell culture techniques
3.3.2.2. Scalability issues with culturing methods
3.3.2.3. Ethical concerns regarding use of animals
3.4. Industry Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.4.2. PESTEL Analysis
3.4.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Europe Cell Culture Market: Product Movement Analysis
4.2. Consumables
4.2.1. Europe Consumables Market, 2018 - 2030 (USD Million)
4.2.2. Media
4.2.2.1. Europe media market, 2018 - 2030 (USD Million)
4.2.2.2. Serum-free media
4.2.2.2.1. Europe serum-free media market, 2018 - 2030 (USD Million)
4.2.2.2.2. CHO media
4.2.2.2.2.1. Europe CHO media market, 2018 - 2030 (USD Million)
4.2.2.2.3. BHK medium
4.2.2.2.3.1. Europe BHK medium market, 2018 - 2030 (USD Million)
4.2.2.2.4. Vero medium
4.2.2.2.4.1. Europe Vero medium market, 2018 - 2030 (USD Million)
4.2.2.2.5. HEK 293 Media
4.2.2.2.5.1. Europe HEK 293 media market, 2018 - 2030 (USD Million)
4.2.2.2.6. Other serum-free media
4.2.2.2.6.1. Europe other serum-free media market, 2018 - 2030 (USD Million)
4.2.2.3. Classical media
4.2.2.3.1. Europe classical media market, 2018 - 2030 (USD Million)
4.2.2.4. Stem cell culture media
4.2.2.4.1. Europe stem cell culture media market, 2018 - 2030 (USD Million)
4.2.2.5. Specialty media
4.2.2.5.1. Europe specialty media market, 2018 - 2030 (USD Million)
4.2.2.6. Chemically defined media
4.2.2.6.1. Europe chemically defined media market, 2018 - 2030 (USD Million)
4.2.2.7. Other cell culture media
4.2.2.7.1. Europe other cell culture media market, 2018 - 2030 (USD Million)
4.2.3. Sera
4.2.3.1. Europe sera market, 2018 - 2030 (USD Million)
4.2.3.2. Fetal bovine serum
4.2.3.2.1. Europe fetal bovine serum market, 2018 - 2030 (USD Million)
4.2.3.3. Others
4.2.3.3.1. Europe others market, 2018 - 2030 (USD Million)
4.2.4. Reagents
4.2.4.1. Europe reagents market, 2018 - 2030 (USD Million)
4.2.4.2. Albumin
4.2.4.2.1. Europe albumin market, 2018 - 2030 (USD Million)
4.2.4.3. Others
4.2.4.3.1. Europe others market, 2018 - 2030 (USD Million)
4.3. Instruments
4.3.1. Europe Instruments Market, 2018 - 2030 (USD Million)
4.3.2. Culture Systems
4.3.2.1. Europe culture systems market, 2018 - 2030 (USD Million)
4.3.3. Incubators
4.3.3.1. Europe incubators market, 2018 - 2030 (USD Million)
4.3.4. Centrifuges
4.3.4.1. Europe centrifuges market, 2018 - 2030 (USD Million)
4.3.5. Cryostorage Equipment
4.3.5.1. Europe cryostorage equipment market, 2018 - 2030 (USD Million)
4.3.6. Biosafety Equipment
4.3.6.1. Europe biosafety equipment market, 2018 - 2030 (USD Million)
4.3.7. Pipetting Instruments
4.3.7.1. Europe pipetting instruments market, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Europe Cell Culture Market: Application Movement Analysis
5.2. Biopharmaceutical Production
5.2.1. Europe Biopharmaceutical Production Market, 2018 - 2030 (USD Million)
5.2.2. Monoclonal Antibodies
5.2.2.1. Europe Monoclonal antibodies market, 2018 - 2030 (USD Million)
5.2.3. Vaccine Production
5.2.3.1. Europe vaccines production market, 2018 - 2030 (USD Million)
5.2.4. Other Therapeutic Proteins
5.2.4.1. Europe other therapeutic proteins market, 2018 - 2030 (USD Million)
5.3. Drug Development
5.3.1. Europe Drug Development Market, 2018 - 2030 (USD Million)
5.4. Diagnostics
5.4.1. Europe Diagnostics Market, 2018 - 2030 (USD Million)
5.5. Tissue Culture & Engineering
5.5.1. Europe Tissue Culture & Engineering Market, 2018 - 2030 (USD Million)
5.6. Cell and Gene Therapy
5.6.1. Europe Cell And Gene Therapy Market, 2018 - 2030 (USD Million)
5.7. Toxicity Testing
5.7.1. Europe Toxicity Testing Market, 2018 - 2030 (USD Million)
5.8. Other Applications
5.8.1. Europe Other Applications Market, 2018 - 2030 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Europe
6.1.1. Europe Cell Culture Market, 2018 - 2030 (USD Million)
6.1.2. UK
6.1.2.1. Key Country Dynamics
6.1.2.2. Competitive Scenario
6.1.2.3. Regulatory Framework
6.1.2.4. UK Europe Cell Culture Market, 2018 - 2030 (USD Million)
6.1.3. Germany
6.1.3.1. Key Country Dynamics
6.1.3.2. Competitive Scenario
6.1.3.3. Regulatory Framework
6.1.3.4. Germany Europe Cell Culture Market, 2018 - 2030 (USD Million)
6.1.4. France
6.1.4.1. Key Country Dynamics
6.1.4.2. Competitive Scenario
6.1.4.3. Regulatory Framework
6.1.4.4. France Europe Cell Culture Market, 2018 - 2030 (USD Million)
6.1.5. Italy
6.1.5.1. Key Country Dynamics
6.1.5.2. Competitive Scenario
6.1.5.3. Regulatory Framework
6.1.5.4. Italy Europe Cell Culture Market, 2018 - 2030 (USD Million)
6.1.6. Spain
6.1.6.1. Key Country Dynamics
6.1.6.2. Competitive Scenario
6.1.6.3. Regulatory Framework
6.1.6.4. Spain Europe Cell Culture Market, 2018 - 2030 (USD Million)
6.1.7. Denmark
6.1.7.1. Key Country Dynamics
6.1.7.2. Competitive Scenario
6.1.7.3. Regulatory Framework
6.1.7.4. Denmark Europe Cell Culture Market, 2018 - 2030 (USD Million)
6.1.8. Sweden
6.1.8.1. Key Country Dynamics
6.1.8.2. Competitive Scenario
6.1.8.3. Regulatory Framework
6.1.8.4. Sweden Europe Cell Culture Market, 2018 - 2030 (USD Million)
6.1.9. Norway
6.1.9.1. Key Country Dynamics
6.1.9.2. Competitive Scenario
6.1.9.3. Regulatory Framework
6.1.9.4. Norway Europe Cell Culture Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.3. Company Market Share Analysis, 2022
7.4. Company Profiles/Listing
7.4.1. Danaher
7.4.1.1. Overview
7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Thermo Fisher Scientific, Inc.
7.4.2.1. Overview
7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Merck KGaA
7.4.3.1. Overview
7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Sartorius AG
7.4.4.1. Overview
7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Corning Inc.
7.4.5.1. Overview
7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. BD
7.4.6.1. Overview
7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Avantor, Inc.
7.4.7.1. Overview
7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Eppendorf SE
7.4.8.1. Overview
7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. PromoCell GmbH
7.4.9.1. Overview
7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Bio-Techne
7.4.10.1. Overview
7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Europe Cell Culture Market, By Product, 2018 - 2030 (USD Million)
Table 4 Europe Cell Culture Market, By Application, 2018 - 2030 (USD Million)
Table 5 Europe Cell Culture Market, By Country, 2018 - 2030 (USD Million)
Table 6 UK Cell Culture Market, By Product, 2018 - 2030 (USD Million)
Table 7 UK Cell Culture Market, By Application, 2018 - 2030 (USD Million)
Table 8 Germany Cell Culture Market, By Product, 2018 - 2030 (USD Million)
Table 9 Germany Europe Cell Culture Market, By Application, 2018 - 2030 (USD Million)
Table 10 France Cell Culture Market, By Product, 2018 - 2030 (USD Million)
Table 11 France Cell Culture Market, By Application, 2018 - 2030 (USD Million)
Table 12 Spain Cell Culture Market, By Product, 2018 - 2030 (USD Million)
Table 13 Spain Cell Culture Market, By Application, 2018 - 2030 (USD Million)
Table 14 Italy Cell Culture Market, By Product, 2018 - 2030 (USD Million)
Table 15 Italy Cell Culture Market, By Application, 2018 - 2030 (USD Million)
Table 16 Denmark Cell Culture Market, By Product, 2018 - 2030 (USD Million)
Table 17 Denmark Cell Culture Market, By Application, 2018 - 2030 (USD Million)
Table 18 Norway Cell Culture Market, By Product, 2018 - 2030 (USD Million)
Table 19 Norway Cell Culture Market, By Application, 2018 - 2030 (USD Million)
Table 20 Sweden Cell Culture Market, By Product, 2018 - 2030 (USD Million)
Table 21 Sweden Cell Culture Market, By Application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Europe cell culture market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot
Fig. 14 Competitive landscape snapshot
Fig. 15 Life science tools market value, 2022 (USD billion)
Fig. 16 Market trends & outlook
Fig. 17 PESTEL analysis
Fig. 18 Porter’s five forces analysis
Fig. 19 Europe cell culture market: Product outlook & key takeaways
Fig. 20 Europe cell culture market: Product movement analysis
Fig. 21 Europe consumables market, 2018 - 2030 (USD Million)
Fig. 22 Europe media market, 2018 - 2030 (USD Million)
Fig. 23 Europe serum-free media market, 2018 - 2030 (USD Million)
Fig. 24 Europe CHO media market, 2018 - 2030 (USD Million)
Fig. 25 Europe BHK medium market, 2018 - 2030 (USD Million)
Fig. 26 Europe Vero medium market, 2018 - 2030 (USD Million)
Fig. 27 Europe HEK 293 media market, 2018 - 2030 (USD Million)
Fig. 28 Europe other serum-free media market, 2018 - 2030 (USD Million)
Fig. 29 Europe classical media market, 2018 - 2030 (USD Million)
Fig. 30 Europe stem cell culture media market, 2018 - 2030 (USD Million)
Fig. 31 Europe specialty media market, 2018 - 2030 (USD Million)
Fig. 32 Europe chemically defined media market, 2018 - 2030 (USD Million)
Fig. 33 Europe other cell culture media market, 2018 - 2030 (USD Million)
Fig. 34 Europe sera market, 2018 - 2030 (USD Million)
Fig. 35 Europe fetal bovine serum market, 2018 - 2030 (USD Million)
Fig. 36 Europe others market, 2018 - 2030 (USD Million)
Fig. 37 Europe reagents market, 2018 - 2030 (USD Million)
Fig. 38 Europe albumin market, 2018 - 2030 (USD Million)
Fig. 39 Europe others market, 2018 - 2030 (USD Million)
Fig. 40 Europe instruments market, 2018 - 2030 (USD Million)
Fig. 41 Europe culture systems market, 2018 - 2030 (USD Million)
Fig. 42 Europe incubators market, 2018 - 2030 (USD Million)
Fig. 43 Europe centrifuges market, 2018 - 2030 (USD Million)
Fig. 44 Europe cryostorage equipment market, 2018 - 2030 (USD Million)
Fig. 45 Europe biosafety equipment market, 2018 - 2030 (USD Million)
Fig. 46 Europe pipetting instruments market, 2018 - 2030 (USD Million)
Fig. 47 Europe cell culture market: Application outlook key takeaways
Fig. 48 Europe cell culture market: Application movement analysis
Fig. 49 Europe biopharmaceutical production market, 2018 - 2030 (USD Million)
Fig. 50 Europe monoclonal antibodies market, 2018 - 2030 (USD Million)
Fig. 51 Europe vaccines production market, 2018 - 2030 (USD Million)
Fig. 52 Europe other therapeutic proteins market, 2018 - 2030 (USD Million)
Fig. 53 Europe drug development market, 2018 - 2030 (USD Million)
Fig. 54 Europe diagnostics market, 2018 - 2030 (USD Million)
Fig. 55 Europe tissue culture & engineering market, 2018 - 2030 (USD Million)
Fig. 56 Europe cell and gene therapy market, 2018 - 2030 (USD Million)
Fig. 57 Europe toxicity testing market, 2018 - 2030 (USD Million)
Fig. 58 Europe other applications market, 2018 - 2030 (USD Million)
Fig. 59 Regional marketplace: Key takeaways
Fig. 60 Regional marketplace: Key takeaways
Fig. 61 Europe cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Germany cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 UK cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 France cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Italy cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Spain cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Denmark cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Sweden cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Norway cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Market participant categorization
Fig. 79 Europe cell culture market share analysis, 2022
Fig. 80 Strategic framework